Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$63.66
0.180.28%
al cierre: -
$63.66
0.000.00%
After hour: Oct 24, 4:00 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Corteva Inc ha un obiettivo di prezzo di consenso pari a $70.85, stabilito in base alle ultime valutazioni degli analisti di 29. Le ultime 3 valutazioni degli analisti sono state rilasciate da Wells Fargo, Argus Research y Mizuho il octubre 16, 2025, octubre 13, 2025 y octubre 8, 2025. Con un obiettivo di prezzo medio di $79.33 tra le Wells Fargo, Argus Research y Mizuho, c'è un implicito 24.62% upside per Corteva Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Wells Fargo
Argus Research
Mizuho
UBS
Citigroup
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Corteva
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/16/2025 | 25.67% | Wells Fargo | $83 → $80 | Maintains | Overweight | |||
10/13/2025 | 25.67% | Argus Research | $83 → $80 | Maintains | Buy | |||
10/08/2025 | 22.53% | Mizuho | $85 → $78 | Maintains | Outperform | |||
10/06/2025 | 33.52% | UBS | $91 → $85 | Maintains | Buy | |||
10/03/2025 | — | Keybanc | — | Downgrade | Overweight → Sector Weight | |||
10/02/2025 | 5.25% | Citigroup | $83 → $67 | Downgrade | Buy → Neutral | |||
10/02/2025 | 9.96% | JP Morgan | → $70 | Upgrade | Neutral → Overweight | |||
08/13/2025 | 31.95% | Barclays | $75 → $84 | Upgrade | Equal-Weight → Overweight | |||
08/08/2025 | 30.38% | Wells Fargo | $82 → $83 | Maintains | Overweight | |||
08/08/2025 | 33.52% | Keybanc | $84 → $85 | Maintains | Overweight | |||
08/07/2025 | 42.95% | UBS | $90 → $91 | Maintains | Buy | |||
07/15/2025 | 36.66% | Oppenheimer | $75 → $87 | Maintains | Outperform | |||
07/14/2025 | 31.95% | Keybanc | $72 → $84 | Maintains | Overweight | |||
07/10/2025 | 33.52% | RBC Capital | $74 → $85 | Maintains | Outperform | |||
07/09/2025 | 41.38% | UBS | $76 → $90 | Maintains | Buy | |||
07/08/2025 | 35.09% | BMO Capital | $74 → $86 | Maintains | Outperform | |||
07/07/2025 | 17.81% | Barclays | $70 → $75 | Maintains | Equal-Weight | |||
06/23/2025 | 28.81% | Wells Fargo | $79 → $82 | Maintains | Overweight | |||
06/06/2025 | 44.52% | Jefferies | $80 → $92 | Maintains | Buy | |||
05/14/2025 | 9.96% | Barclays | $64 → $70 | Maintains | Equal-Weight | |||
05/12/2025 | 24.1% | Wells Fargo | $73 → $79 | Maintains | Overweight | |||
05/09/2025 | 17.81% | Oppenheimer | $72 → $75 | Reiterates | Outperform → Outperform | |||
05/09/2025 | 11.53% | Morgan Stanley | $65 → $71 | Maintains | Overweight | |||
05/09/2025 | 22.53% | Citigroup | $75 → $78 | Maintains | Buy | |||
05/09/2025 | 13.1% | Keybanc | $71 → $72 | Maintains | Overweight | |||
05/08/2025 | 19.38% | UBS | $74 → $76 | Maintains | Buy | |||
04/14/2025 | 11.53% | Keybanc | $70 → $71 | Maintains | Overweight | |||
03/31/2025 | 8.39% | Argus Research | $69 → $69 | Upgrade | Hold → Buy | |||
03/13/2025 | 11.53% | Goldman Sachs | → $71 | Initiates | → Buy | |||
02/11/2025 | 14.67% | B of A Securities | $69 → $73 | Maintains | Buy | |||
02/07/2025 | 14.67% | RBC Capital | $72 → $73 | Maintains | Outperform | |||
02/07/2025 | 13.1% | Oppenheimer | $70 → $72 | Maintains | Outperform | |||
02/07/2025 | 9.96% | Keybanc | $68 → $70 | Maintains | Overweight | |||
01/29/2025 | 16.24% | Citigroup | $69 → $74 | Maintains | Buy | |||
01/28/2025 | 13.1% | RBC Capital | $73 → $72 | Maintains | Outperform | |||
01/28/2025 | 14.67% | Wells Fargo | $67 → $73 | Maintains | Overweight | |||
01/21/2025 | 0.53% | Barclays | $62 → $64 | Maintains | Equal-Weight | |||
01/10/2025 | 14.67% | UBS | $74 → $73 | Maintains | Buy | |||
01/10/2025 | 6.82% | Keybanc | $69 → $68 | Maintains | Overweight | |||
12/19/2024 | 14.67% | RBC Capital | $68 → $73 | Maintains | Outperform | |||
12/18/2024 | 8.39% | Citigroup | $70 → $69 | Maintains | Buy | |||
12/05/2024 | 16.24% | UBS | $71 → $74 | Maintains | Buy | |||
11/21/2024 | 8.39% | Keybanc | $66 → $69 | Maintains | Overweight | |||
11/20/2024 | 5.25% | Wells Fargo | $65 → $67 | Maintains | Overweight | |||
11/20/2024 | 8.39% | B of A Securities | $67 → $69 | Maintains | Buy | |||
11/11/2024 | 6.82% | RBC Capital | $69 → $68 | Maintains | Outperform | |||
11/08/2024 | -2.61% | Barclays | $58 → $62 | Maintains | Equal-Weight | |||
11/08/2024 | 9.96% | Oppenheimer | $69 → $70 | Reiterates | Outperform → Outperform | |||
11/07/2024 | 11.53% | UBS | $67 → $71 | Maintains | Buy | |||
10/23/2024 | 6.82% | Citigroup | → $68 | Initiates | → Buy | |||
10/16/2024 | 5.25% | B of A Securities | $59 → $67 | Upgrade | Neutral → Buy | |||
09/24/2024 | 2.1% | Morgan Stanley | $65 → $65 | Maintains | Overweight | |||
08/07/2024 | — | Argus Research | — | Downgrade | Buy → Hold | |||
08/02/2024 | -13.6% | JP Morgan | $57 → $55 | Maintains | Neutral | |||
08/02/2024 | 2.1% | Wells Fargo | $67 → $65 | Maintains | Overweight | |||
08/02/2024 | -2.61% | Keybanc | $66 → $62 | Maintains | Overweight | |||
06/18/2024 | -5.75% | Mizuho | $61 → $60 | Maintains | Buy | |||
06/12/2024 | 2.1% | Deutsche Bank | $65 → $65 | Maintains | Buy | |||
06/07/2024 | — | OTR Global | — | — | Downgrade | Mixed → Negative | ||
05/06/2024 | 2.1% | Deutsche Bank | $62 → $65 | Maintains | Buy | |||
05/06/2024 | 0.53% | RBC Capital | $62 → $64 | Maintains | Outperform | |||
05/03/2024 | 2.1% | Canaccord Genuity | $60 → $65 | Maintains | Buy | |||
05/03/2024 | 5.25% | Wells Fargo | $66 → $67 | Maintains | Overweight | |||
05/03/2024 | 5.25% | BMO Capital | $64 → $67 | Maintains | Outperform | |||
05/03/2024 | 8.39% | Oppenheimer | $67 → $69 | Maintains | Outperform | |||
05/02/2024 | -4.18% | Mizuho | $56 → $61 | Maintains | Buy | |||
04/16/2024 | 5.25% | Oppenheimer | $62 → $67 | Maintains | Outperform | |||
04/12/2024 | -10.46% | JP Morgan | $58 → $57 | Downgrade | Overweight → Neutral | |||
04/10/2024 | -8.89% | Barclays | $55 → $58 | Maintains | Equal-Weight | |||
04/09/2024 | 3.68% | Keybanc | $63 → $66 | Maintains | Overweight | |||
03/01/2024 | — | Wolfe Research | — | Initiates | → Outperform | |||
02/12/2024 | 2.1% | Loop Capital | $57 → $65 | Upgrade | Hold → Buy | |||
02/02/2024 | -2.61% | Oppenheimer | $60 → $62 | Maintains | Outperform | |||
02/02/2024 | 0.53% | RBC Capital | $56 → $64 | Maintains | Outperform | |||
02/02/2024 | -1.04% | Keybanc | $62 → $63 | Maintains | Overweight | |||
02/02/2024 | 2.1% | Wells Fargo | $54 → $65 | Maintains | Overweight | |||
02/02/2024 | -13.6% | Barclays | $50 → $55 | Maintains | Equal-Weight | |||
02/02/2024 | -16.75% | Exane BNP Paribas | → $53 | Upgrade | Underperform → Neutral | |||
02/01/2024 | -12.03% | Mizuho | $59 → $56 | Maintains | Buy | |||
01/11/2024 | 0.53% | UBS | $65 → $64 | Maintains | Buy | |||
11/27/2023 | -18.32% | Berenberg | $63 → $52 | Downgrade | Buy → Hold | |||
11/22/2023 | -1.04% | Roth MKM | $82 → $63 | Maintains | Buy | |||
11/14/2023 | -21.46% | Barclays | $66 → $50 | Downgrade | Overweight → Equal-Weight | |||
11/10/2023 | -12.03% | RBC Capital | $61 → $56 | Maintains | Outperform | |||
11/10/2023 | -5.75% | Morgan Stanley | $80 → $60 | Maintains | Overweight | |||
11/10/2023 | -2.61% | Keybanc | $66 → $62 | Maintains | Overweight | |||
10/30/2023 | -8.89% | Fermium Research | $72 → $58 | Maintains | Outperform | |||
10/30/2023 | -4.18% | RBC Capital | $67 → $61 | Maintains | Outperform | |||
10/30/2023 | 0.53% | BMO Capital | $70 → $64 | Maintains | Outperform | |||
10/24/2023 | -12.03% | Goldman Sachs | $65 → $56 | Maintains | Neutral | |||
10/23/2023 | 3.68% | Wells Fargo | $73 → $66 | Maintains | Overweight | |||
10/20/2023 | 5.25% | Oppenheimer | → $67 | Upgrade | Perform → Outperform | |||
10/10/2023 | 11.53% | Mizuho | $72 → $71 | Maintains | Buy | |||
09/05/2023 | 5.25% | UBS | $63 → $67 | Upgrade | Neutral → Buy | |||
08/17/2023 | 6.82% | Argus Research | $78 → $68 | Maintains | Buy | |||
08/14/2023 | 5.25% | Barclays | $70 → $67 | Maintains | Overweight | |||
08/07/2023 | 2.1% | JP Morgan | $70 → $65 | Maintains | Overweight | |||
08/07/2023 | 14.67% | Wells Fargo | $74 → $73 | Maintains | Overweight | |||
08/07/2023 | 13.1% | Mizuho | $74 → $72 | Maintains | Buy | |||
08/07/2023 | 3.68% | Keybanc | $68 → $66 | Maintains | Overweight |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Corteva (CTVA)?
El último precio objetivo de Corteva (NYSE:CTVA) fue comunicado por Wells Fargo el octubre 16, 2025. La firma de analistas fijó un precio objetivo para $80.00 que espera CTVA a rise dentro de 12 meses (un posible 25.67% upside). 49 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Corteva (CTVA)?
La última calificación de analistas para Corteva (NYSE:CTVA) fue proporcionada por Wells Fargo, y Corteva mantuvo su overweight calificación.
¿Cuándo se produjo la última revisión al alza de Corteva (CTVA)?
La última revisión al alza de Corteva Inc se produjo en octubre 2, 2025, cuando JP Morgan elevó su precio objetivo a $70. JP Morgan anteriormente tenía a neutral para Corteva Inc.
¿Cuándo fue la última revisión a la baja de Corteva (CTVA)?
La última revisión a la baja de Corteva Inc se produjo en octubre 3, 2025, cuando Keybanc cambió su precio objetivo de N/A a N/A para Corteva Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Corteva (CTVA)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Corteva, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Corteva se registró el octubre 16, 2025, por lo que la próxima calificación estará disponible en torno al octubre 16, 2026.
¿Es correcta la calificación de los analistas sobre Corteva (CTVA)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Corteva (CTVA) fue un mantuvo con un precio objetivo de $83.00 a $80.00. El precio actual al que cotiza Corteva (CTVA) es de $63.66, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.